REG - ConvaTec Group PLC - Director/PDMR Shareholding

ConvaTecAnnouncement

18/10/2021 16:35

RNS Number : 4287P
  
ConvaTec Group PLC
  
18 October 2021
  
 

18 October 2021
ConvaTec Group Plc

("ConvaTec" or "the Company")

Director/PDMR Shareholding
The Company has been notified of the following transactions by Persons Discharging Managerial Responsibility ("PDMR") in ordinary shares of 10 pence each in the share capital of the Company ("Shares").
On 14 October 2021, Frank Schulkes, Chief Financial Officer and a PDMR, received 25 Shares at £2.024 per share under the terms of the Dividend Reinvestment Plan, operated by the Company's registrars for employees holding shares within its Share Plan Account. Mr Schulkes' resulting shareholding is 169,180 Shares.
Further, on the same day, Rick Anderson, Non-Executive Director and a PDMR, received 433 Shares at £2.2608 per share under the Scrip Dividend Scheme. Mr Anderson's resulting shareholding is 210,706 Shares. 
The attached notification, made in accordance with the requirements of the EU Market Abuse Regulation, gives further detail. 
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM



1


Details of the person discharging managerial responsibilities/person closely associated




a)


Name


Frank Schulkes




2


Reason for the notification




a)


Position/Status


Chief Financial Officer




b)


Initial notification/Amendment


Initial notification




3


Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor




a)


Name


ConvaTec Group Plc




b)


LEI


213800LS272L4FIDOH92




4


Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted




a) 


Description of the financial instrument, type of instrument 
Identification code


Ordinary shares of 10p each in ConvaTec Group Plc ("Shares")
GB00BD3VFW73




b) 


Nature of the transaction


Receipt of Shares under the terms of the Dividend  
Reinvestment Plan operated by the Company's registrars for employees holding shares within its Share Plan Account. 
 
 




c) 


Price(s) and volume(s)


Price(s)
£2.024


Volume(s)
25




d)


Aggregated information
- Aggregated volume  
- Price


 
N/A
N/A




e)


Date of the transaction


14 October 2021




f)


Place of the transaction


Outside a trading venue

























         



1


Details of the person discharging managerial responsibilities/person closely associated




a)


Name


Rick Anderson




2


Reason for the notification




a)


Position/Status


Non-Executive Director




b)


Initial notification/Amendment


Initial notification




3


Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor




a)


Name


ConvaTec Group Plc




b)


LEI


213800LS272L4FIDOH92




4


Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted




a) 


Description of the financial instrument, type of instrument 
Identification code


Ordinary shares of 10p each in ConvaTec Group Plc ("Shares")
GB00BD3VFW73




b) 


Nature of the transaction


  Receipt of Shares under Scrip Dividend Scheme
 




c) 


Price(s) and volume(s)


Price(s)
£2.2608


Volume(s)
433




d)


Aggregated information
- Aggregated volume  
- Price


 
N/A
N/A




e)


Date of the transaction


14 October 2021




f)


Place of the transaction


Outside a trading venue

























 
Enquiries
Analysts and Investors
Kate Postans, VP Investor Relations, ConvaTec                      +44 (0)782 644 7807
ir@convatec.com
 
Media
Buchanan: Charles Ryland / Chris Lane                                    +44 (0)207 466 5000                                                                                                  
ConvaTec Group Plc's LEI code is 213800LS272L4FIDOH92
About ConvaTec
ConvaTec is a global medical products and technologies company focused on therapies for the management of chronic conditions, with leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion care. Our vision, which encompasses our purpose, is: Pioneering trusted medical solutions to improve the lives we touch. Our products provide a range of clinical and economic benefits including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. To learn more about ConvaTec, please visit www.convatecgroup.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
  END
 
 
DSHFLFSSITLTLIL